Tag: monoclonal

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England

FDA authorizes third Covid antibody treatment that cuts risk of hospitalization or death by 85% Sotrovimab is the third monoclonal antibody drug to receive approval for use fighting Covid-19, fifth drug overall Believed to be able to reduce Covid hospitalizations and deaths by 85 percent   The drug will be the first to have a point

COVID-19 (coronavirus) patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalization or emergency medical care than those who did not receive the antibody, according to a new study published in the The New England Journal of Medicine. The multisite, Phase II clinical trial tested three different doses